Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Survival Tree01:19

Survival Tree

497
Survival trees are a non-parametric method used in survival analysis to model the relationship between a set of covariates and the time until an event of interest occurs, often referred to as the "time-to-event" or "survival time." This method is particularly useful when dealing with censored data, where the event has not occurred for some individuals by the end of the study period, or when the exact time of the event is unknown.
 Building a Survival Tree
Constructing a...
497
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

489
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
489
Truncation in Survival Analysis01:09

Truncation in Survival Analysis

718
Truncation in survival analysis refers to the exclusion of individuals or events from the dataset based on specific criteria related to the time of the event. This exclusion can happen in two primary forms: left truncation and right truncation.
Left truncation occurs when individuals who experienced the event of interest before a certain time are not included in the study. This is often due to a "delayed entry" into the study where only those who survive until a certain entry point are...
718
Parametric Survival Analysis: Weibull and Exponential Methods01:14

Parametric Survival Analysis: Weibull and Exponential Methods

1.3K
Parametric survival analysis models survival data by assuming a specific probability distribution for the time until an event occurs. The Weibull and exponential distributions are two of the most commonly used methods in this context, due to their versatility and relatively straightforward application.
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
1.3K
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

974
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
974
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

711
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
711

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

CytoScan: Automated Detection of Technical Anomalies for Cytometry Quality Control.

Cytometry. Part A : the journal of the International Society for Analytical Cytology·2026
Same author

Protocadherin-1 deficiency increases baseline and allergen-induced airway hyperresponsiveness in mice.

American journal of respiratory cell and molecular biology·2026
Same author

The Ste20 kinase TAOK3 restrains Rac-driven cytoskeletal-mitochondrial coupling to preserve naive CD8<sup>+</sup> T cell homeostasis and activation.

Frontiers in immunology·2026
Same author

CARGO: A Cytometry Analysis framework via Regularized Graph Optimal-transport.

PLoS computational biology·2026
Same author

Endothelial cells notch monocytes toward an alveolar macrophage fate.

The Journal of experimental medicine·2026
Same author

Multivalent Antibody-Recruiting Molecules for Targeted Immune-Killing of Carbonic Anhydrase IX-Expressing Cancer Cells.

Angewandte Chemie (International ed. in English)·2026

Related Experiment Video

Updated: Apr 5, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

11.0K

FloReMi: Flow density survival regression using minimal feature redundancy.

Sofie Van Gassen1,2,3, Celine Vens2,3,4, Tom Dhaene1

  • 1Department of Information Technology, Ghent University-iMinds, Ghent, Belgium.

Cytometry. Part a : the Journal of the International Society for Analytical Cytology
|August 6, 2015
PubMed
Summary
This summary is machine-generated.

A new method, FloReMi, accurately predicts AIDS progression in HIV patients using flow cytometry data. This approach outperformed others in the FlowCAP IV challenge, offering valuable insights into immunopathogenesis.

Keywords:
feature selectionmachine learningpolychromatic flow cytometrysurvival time prediction

More Related Videos

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

1.5K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

8.1K

Related Experiment Videos

Last Updated: Apr 5, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

11.0K
Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

1.5K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

8.1K

Area of Science:

  • Immunology
  • Bioinformatics
  • Computational Biology

Background:

  • Flow cytometry bioinformatics offers diverse clustering, classification, and visualization tools.
  • Objective evaluation of these methods is essential, with benchmarks like FlowCAP being valuable.
  • HIV patient progression rates vary and are not fully predictable by CD4(+) T cell counts alone.

Purpose of the Study:

  • To introduce FloReMi, a novel method developed for the FlowCAP IV challenge.
  • To predict time to AIDS progression in HIV patients using survival modeling.
  • To explore early immunopathogenesis as an indicator of future disease course.

Main Methods:

  • Developed FloReMi, a novel method for the FlowCAP IV challenge.
  • Utilized an automated pipeline for data preprocessing and informative cell subset identification.
  • Employed a survival regression model based on random survival forests.

Main Results:

  • FloReMi achieved the best performance among all submitted approaches in the FlowCAP IV challenge.
  • The method successfully predicted time to AIDS progression for HIV patients.
  • Identified informative cell subsets crucial for survival modeling.

Conclusions:

  • FloReMi offers a robust approach to survival modeling in HIV patient data.
  • Early immunopathogenesis, as analyzed by flow cytometry, can predict disease progression.
  • This method provides a valuable tool for estimating HIV patient progression rates for improved treatment.